Skip to content

Depression: all studies

Page 596 of 1,034: studies 5,951 to 5,960 of 10,336, newest first. Back to the depression overview

Research

Mental disorder and its treatment as a transformative experience

Phenomenology and the Cognitive Sciences February 8, 2025 Daniel Villiger 1 citation

Abstract According to L.A. Paul, undergoing an experience is transformative if we learn something we cannot learn without having the experience and if it substantially changes our point of view. While the implications of transformative experiences have primarily been discussed in the context of rational choice, their underlying concept has also proven fruitful in the context of unchosen...

DOI: 10.1007/s11097-025-10059-6 (opens in new tab) Full text (opens in new tab) Philosophy of mind Transformative learning Phenomenology philosophy Psychotherapist +3

SUBJECTIVE EXPERIENCES OF AYAHUASCA NAIVE USERS

February 5, 2025 Lucas Villar Magalhães da Cruz

[pt] A ayahuasca é uma infusão psicoativa utilizada como enteógeno há séculos, com pesquisas recentes indicando seu potencial como um tratamento promissor para certos transtornos clínicos. Apesar do crescente corpo de literatura científica sobre seus efeitos, ainda há uma escassez de estudos que investiguem as experiências subjetivas de usuários ingênuos de ayahuasca. O primeiro estudo desta...

Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners

Journal of Psychedelic Studies February 5, 2025 Shannon Hughes, Lucia Terpak, Reilly Capps et al. 2 citations

Abstract Background and Aims Networks of so-called underground, or illegal, psilocybin mushroom practitioners are popularly known to exist, though few systematic investigations of their practices have been conducted. We sought to uncover the experiences of a hidden community of psilocybin practitioners in order to inform scientific and policy dialogues about safe and effective practices in this...

DOI: 10.1556/2054.2025.00375 (opens in new tab) Psilocybin Stewardship theology Mushroom poisoning Hallucinogen

From strain to strength: a yearlong study on the transformative influence of inner engineering online program on mental well-being

Frontiers in Psychology February 4, 2025 Ashwin Swaminathan, Braiden DeSchryver, Akila Rayapuraju et al.

Introduction Health is a multidimensional phenomenon encompassing physical, mental, and social well-being, all of which are deeply interconnected. The COVID-19 pandemic highlighted the importance of mental and social health, as rates of loneliness, depression, and anxiety surged. Mindfulness practices, such as Shambhavi Mahamudra Kriya (SMK), have gained attention for their potential to enhance...

Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.

Psychopharmacology Bulletin February 3, 2025 Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi 8 citations

Hallucinogen-persisting Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of one or more perceptual symptoms that an individual experienced while intoxicated with a hallucinogenic substance when the individual is sober. While there are several case reports of HPPD in adult patients, there is a scarcity of documented cases in children and adolescents. The...

DOI: 10.1016/j.biopha.2021.112295 (opens in new tab) Full text (opens in new tab) Hallucinogen-persisting perception disorder Hallucinogenic use Mental illness Polysubstance use +3

A novel antidepressant intervention for outpatient psychiatry

Journal of Prescribing Practice February 2, 2025 Gryan Garcia

This article explores the potential of the novel antidepressant dextromethorphan-bupropion in addressing treatment-resistant depression (TRD). Traditional approaches, including selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors, alongside antipsychotic agents, often prove insufficient. Amid a global surge in TRD post-COVID-19, dextromethorphan-bupropion...

Stress, Coping, and Transcendental Meditation: A Proto-Theoretical Model and Pilot Study of Indigenous Peruvian Students in Home Isolation During the COVID-19 Pandemic

Journal of Latinos & Education February 2, 2025 Lee Fergusson, Javier Ortiz Cabrejos, Anna Bonshek

ABSTRACT Adverse impacts on children in home isolation during the COVID-19 pandemic have been documented. These impacts include increased loneliness, anxiety, depression, posttraumatic disorder, and heightened risk of psychiatric illness. The present study introduces a proto-theoretical model of stress, psychophysiology, and coping to explain this phenomenon. A focus of the research is on...

SUPPLEMENTING WITH DEXTROMETHORPHAN MAY ENHANCE COGNITIVE FUNCTIONS IN YOUNG INDIVIDUALS WITH BIPOLAR DISORDERS

The International Journal of Neuropsychopharmacology February 1, 2025 Chih-Chun Huang, Y. Chang, Ru-Band Lu et al.

Abstract Background Bipolar disorder (BD) is a chronic, debilitating mental condition with consistent prevalence across genders and ethnicities. It's marked by high relapse rates, mood swings, and disruptions in various life aspects. Prior research has highlighted neuropsychological impairments in BD. Aims & Objectives This study investigates the therapeutic effect of dextromethorphan (DM), an...

BEHAVIORAL ANALYSES OF ANTIDEPRESSANT-LIKE EFFECT OF SEROTONERGIC PSYCHEDELICS IN MICE

The International Journal of Neuropsychopharmacology February 1, 2025 *Daisuke Ibi, Rika Takaba, Keisuke Yoshida et al.

Abstract Background Serotonergic psychedelics such as psilocybin, lysergic acid diethylamide, and DOI exert a hallucinatory effect through the serotonin 5-HT2A receptor (5-HT2A). Recent studies have revealed that serotonergic psychedelics have therapeutic potential for neuropsychiatric disorders, including major depressive and anxiety-related disorders. Aims & Objectives The involvement of...

Muscarinic cannabinoid suppression of excitation, a novel form of coincidence detection.

Pharmacological Research February 1, 2025 Michaela Dvorakova, Ken Mackie, Alex Straiker 2 citations

Δ9-tetrahydrocannabinol (THC), the chief psychoactive ingredient of cannabis, acts in the brain primarily via cannabinoid CB1 receptors. These receptors are implicated in several forms of synaptic plasticity - depolarization-induced suppression of excitation (DSE), metabotropic suppression of excitation (MSE), long term depression (LTD) and activation-dependent desensitization. Cultured...

DOI: 10.1016/j.phrs.2025.107606 (opens in new tab) Full text (opens in new tab) Synaptic plasticity Autaptic hippocampal neurons Cb1 receptor M3/m5 muscarinic receptors